JP2009535298A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2009535298A5 JP2009535298A5 JP2009502932A JP2009502932A JP2009535298A5 JP 2009535298 A5 JP2009535298 A5 JP 2009535298A5 JP 2009502932 A JP2009502932 A JP 2009502932A JP 2009502932 A JP2009502932 A JP 2009502932A JP 2009535298 A5 JP2009535298 A5 JP 2009535298A5
- Authority
- JP
- Japan
- Prior art keywords
- cell
- cancer
- anticancer agent
- cancer cells
- agent according
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US11/389,695 US9107863B2 (en) | 2006-03-27 | 2006-03-27 | Reagents and methods for cancer treatment and prevention |
| US11/389,695 | 2006-03-27 | ||
| PCT/US2007/007526 WO2007126787A2 (en) | 2006-03-27 | 2007-03-27 | Reagents and methods for cancer treatment and prevention |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2013170115A Division JP5712257B2 (ja) | 2006-03-27 | 2013-08-20 | 癌の処置および予防のための試薬および方法 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2009535298A JP2009535298A (ja) | 2009-10-01 |
| JP2009535298A5 true JP2009535298A5 (https=) | 2011-05-12 |
| JP5422377B2 JP5422377B2 (ja) | 2014-02-19 |
Family
ID=38533710
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2009502932A Expired - Fee Related JP5422377B2 (ja) | 2006-03-27 | 2007-03-27 | 癌の処置および予防のための試薬および方法 |
| JP2013170115A Expired - Fee Related JP5712257B2 (ja) | 2006-03-27 | 2013-08-20 | 癌の処置および予防のための試薬および方法 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2013170115A Expired - Fee Related JP5712257B2 (ja) | 2006-03-27 | 2013-08-20 | 癌の処置および予防のための試薬および方法 |
Country Status (8)
| Country | Link |
|---|---|
| US (4) | US9107863B2 (https=) |
| EP (2) | EP2004219B1 (https=) |
| JP (2) | JP5422377B2 (https=) |
| CN (1) | CN101443036A (https=) |
| AU (1) | AU2007245169B2 (https=) |
| CA (1) | CA2647542A1 (https=) |
| ES (2) | ES2655909T3 (https=) |
| WO (1) | WO2007126787A2 (https=) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP3376495B2 (ja) | 1992-08-18 | 2003-02-10 | ソニー株式会社 | 接着剤の塗布方法及び接着治具 |
| US9107863B2 (en) | 2006-03-27 | 2015-08-18 | The Buck Institute For Age Reasearch | Reagents and methods for cancer treatment and prevention |
| CZ300806B6 (cs) * | 2007-07-18 | 2009-08-12 | Ústav experimentální mediciny AV CR, v.v.i. | Imunostimulacní úcinky trilobolidu a zpusob jeho prípravy |
| HK1213740A1 (zh) * | 2013-03-15 | 2016-07-15 | Inspyr Therapeutics, Inc. | 制备抗癌症组合物的方法 |
| EP2796137A1 (en) * | 2013-04-22 | 2014-10-29 | Universität des Saarlandes | SERCA inhibitor and Calmodulin antagonist combination |
| CN112891354B (zh) * | 2021-03-18 | 2022-10-21 | 新乡医学院 | MDM2抑制剂Nutlin-3a在制备激活内质网应激诱导的癌细胞凋亡药物中的应用 |
Family Cites Families (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4867973A (en) | 1984-08-31 | 1989-09-19 | Cytogen Corporation | Antibody-therapeutic agent conjugates |
| US4671958A (en) | 1982-03-09 | 1987-06-09 | Cytogen Corporation | Antibody conjugates for the delivery of compounds to target sites |
| IN165717B (https=) | 1986-08-07 | 1989-12-23 | Battelle Memorial Institute | |
| US5637483A (en) | 1991-10-04 | 1997-06-10 | Whitehead Institute For Biomedical Research | Irradiated tumor cell vaccine engineered to express GM-CSF |
| US5904920A (en) | 1991-10-04 | 1999-05-18 | Whitehead Institute For Biomedical Research | Regulation of systemic immune responses utilizing cytokines and antigens |
| US20010033839A1 (en) * | 1999-10-04 | 2001-10-25 | Emilio Barbera-Guillem | Vaccine and immunotherapy for solid nonlymphoid tumor and related immune dysregulation |
| AU5458500A (en) | 1999-06-02 | 2000-12-18 | Cell Genesys, Inc. | Regulation of systemic immune responses utilizing cytokines and antigens |
| JP2001010973A (ja) * | 1999-06-29 | 2001-01-16 | Dnavec Research Inc | がんワクチン |
| SK287400B6 (sk) * | 1999-09-25 | 2010-08-09 | University Of Iowa Research Foundation | Prostriedok s obsahom imunostimulačnej nukleovej kyseliny a jeho použitie na stimuláciu imunitnej reakcie |
| US7056491B2 (en) * | 2000-11-08 | 2006-06-06 | Wisconsin Alumni Research Foundation | Monoterpenes and sesquiterpenes as chemotherapeutic and radiation sensitizers and immunomodulators |
| CA2356438A1 (en) * | 2001-09-05 | 2003-03-05 | Andre Pichette | Use of terpenes and derivatives as potentiators of antitumor agents in the treatment of cancers |
| JPWO2003038118A1 (ja) * | 2001-10-31 | 2005-02-24 | 藤沢薬品工業株式会社 | ホスファターゼ阻害因子の評価方法 |
| US20030235818A1 (en) * | 2002-04-08 | 2003-12-25 | Vsevolod Katritch | Immunogenic peptides, and method of identifying same |
| US20060148064A1 (en) | 2002-10-25 | 2006-07-06 | Srivastava Pramod K | Apparatus and method for immunotherapy of a cancer through controlled cell lysis |
| JP5039383B2 (ja) * | 2003-11-30 | 2012-10-03 | イエダ リサーチ アンド ディベロップメント カンパニー リミテッド | 免疫モジュレーションのための方法および薬剤ならびに免疫モジュレーターの同定方法 |
| US9107863B2 (en) | 2006-03-27 | 2015-08-18 | The Buck Institute For Age Reasearch | Reagents and methods for cancer treatment and prevention |
-
2006
- 2006-03-27 US US11/389,695 patent/US9107863B2/en not_active Expired - Fee Related
-
2007
- 2007-03-27 WO PCT/US2007/007526 patent/WO2007126787A2/en not_active Ceased
- 2007-03-27 CA CA002647542A patent/CA2647542A1/en not_active Abandoned
- 2007-03-27 JP JP2009502932A patent/JP5422377B2/ja not_active Expired - Fee Related
- 2007-03-27 AU AU2007245169A patent/AU2007245169B2/en not_active Ceased
- 2007-03-27 EP EP07754097.9A patent/EP2004219B1/en not_active Not-in-force
- 2007-03-27 ES ES15180408.5T patent/ES2655909T3/es active Active
- 2007-03-27 ES ES07754097.9T patent/ES2548435T3/es active Active
- 2007-03-27 CN CNA2007800162837A patent/CN101443036A/zh active Pending
- 2007-03-27 EP EP15180408.5A patent/EP2974738B1/en not_active Not-in-force
-
2010
- 2010-04-29 US US12/770,638 patent/US8895031B2/en active Active
-
2013
- 2013-08-20 JP JP2013170115A patent/JP5712257B2/ja not_active Expired - Fee Related
-
2015
- 2015-07-15 US US14/800,412 patent/US9885704B2/en not_active Expired - Fee Related
-
2017
- 2017-12-22 US US15/852,606 patent/US20180128816A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP7055906B2 (ja) | 細胞膜透過性を増加させるための交流電界の使用 | |
| EP3010497B1 (en) | A combination of tetrahydrocannabinol and cannabidiol for use for increasing radiosensitivity in the treatment of a brain tumour | |
| Sultan et al. | Disulfonated tetraphenyl chlorin (TPCS2a)-induced photochemical internalisation of bleomycin in patients with solid malignancies: a phase 1, dose-escalation, first-in-man trial | |
| Jiang et al. | Preparation and anti-tumor metastasis of carboxymethyl chitosan | |
| SG161307A1 (en) | Oligoribonucleotides and methods of use thereof for treatment of alopecia, acute renal failure and other diseases | |
| BRPI0601736A (pt) | métodos de terapia adjuvante, método de cura de cáncer de mama não metastático, método de redução de reincidência de doenças, método de instrução de pacientes humanos com cáncer de mama her2-positivo não metastático, método de produção e métodos comerciais | |
| GB0223380D0 (en) | Combination therapy | |
| NO20060307L (no) | Anvendelse av kinoazolinderivatet ZD6474 kombinert med platinaforbindelser og eventuelt ioniserende straling i behandling av sykdommer assosoiert med angiogenese og/eller okt vaskulaert permeabilitet | |
| DE60331933D1 (de) | Benutzung von alpha (1,3) -galactosyltransferase exprimierenden allogenen tumorzellen zur impfung gegen tumoren | |
| JP2009535298A5 (https=) | ||
| NO20071426L (no) | Kreft kombinasjonsbehandling omfattende AZD2171 og Imatinib | |
| WO2004073657A3 (en) | Methods of diagnosis of cancer and other diseases, composition and methods of screening for modulators of cancer and other diseases | |
| IL191796A0 (en) | Combination of zd6474 and pemetrexed | |
| Łasińska et al. | Basal cell carcinoma: pathology, current clinical treatment, and potential use of lipid nanoparticles | |
| IL174525A0 (en) | Medicamentously targeted local lipolysis | |
| CY1111353T1 (el) | Χρηση ενωσεων κααλαλιδης για την παραγωγη φαρμακου για τη θεραπεια της ψωριασης | |
| Xu et al. | Endothelial Foxo1 Phosphorylation Inhibition via Aptamer‐Liposome Alleviates OPN‐Induced Pathological Vascular Remodeling Following Spinal Cord Injury | |
| DE60311788D1 (de) | Kombinationstherapie zur behandlung von krebs | |
| PL1653964T3 (pl) | Skojarzone leczenie raka obejmujące AZD2171 i ZD1839 | |
| IL177953A0 (en) | Combination therapy including azd2171 and a taxane | |
| NO20064755L (no) | Kombinasjonsterapi | |
| WO2005092384A3 (en) | Combination therapy with azd2171 and a platinum anti-tumour agent | |
| NO20056171L (no) | Kombinasjonsterapi | |
| Shanmugam et al. | Emerging Therapeutic Strategies in Oral Cancer: Epigenetic, Mitochondrial and Immunotherapy Approaches | |
| Zaker et al. | Gemini curcumin inhibits 4T1 cancer cell proliferation and modulates the expression of apoptotic and metastatic genes on Balb/c Mice model |